Sanuwave's 3% Revenue Slide and Mixed Q2 Signals Show a Business Still Proving Recovery

A headline beat did not erase the underlying problem

Sanuwave's Q2 looks better at first glance than it does under the hood.

The bar was low, and the company only barely cleared it

In June, management cut expectations to revised guidance of $8.5 million to $9.5 million. In July, preliminary Q2 revenue was pegged at $9.6 million to $9.8 million, technically above that lowered bar. The final figure came in at $9.7 million.

That is a beat in the narrow sense, but it does not by itself prove the business is back. The more important question is the quality of the sales behind the number.

The profit engine still has not fully returned

Sanuwave still posted a GAAP operating loss of $(0.3) million after a year-ago profit, which shows recovery is incomplete. Ultramist applicator revenue increased by 13% to $7.3 million, the trend investors want to see hold up. But until that recurring stream can more reliably offset weaker system placements and support stronger earnings, this remains a watchful setup rather than a clear recovery story.

Why the August 7 call matters more than the headline

Sanuwave is hosting a live Q2 2026 earnings call on August 7, 2026 at 8:30 AM ET. The key issue is straightforward: was this quarter helped by a lowered bar and temporary factors, or does it mark the start of a more repeatable upturn?

Sanuwave Q2 mix: consumables grew, but systems still dragged

The more useful read of the quarter is not the headline beat but the revenue mix inside it. Sanuwave appears to be a business with a still-growing consumable stream trying to offset a slowdown in system placements.

System placements fell for a second straight quarter

The equipment side was the clearest pressure point. Sanuwave sold 82 Ultramist systems in Q2 2026, down from 97 in Q1 2026 and 116 in Q2 2025.

Management said capital sales faced headwinds from stress in our customer base and from the sale of used Ultramist systems in the market. In practical terms, some customers appear to be waiting longer to buy new machines or turning to the used market first.

Consumables were still the strongest part of the quarter

The recurring side kept moving forward. Management said consumable applicators set all time records, and the quarter's results showed applicator revenue increased by 13%.

That is the part of the model that matters most if Sanuwave is moving toward more repeat demand after the initial system sale.

Why stronger consumables did not protect earnings

A higher share of consumables should, in theory, support margins. Gross margin was still solid at 76.2% in Q2 2026, though slightly below 78.1% a year earlier. Even so, the shift was not enough to fully offset the slowdown.

The bigger issue is operating leverage. Fixed costs do not automatically fall when system sales weaken. As a result, Sanuwave ended Q2 with a GAAP operating loss of $(0.3) million, versus $1.4 million of operating income a year earlier. That followed Q1 2026 earnings of -$1.4 million after fiscal 2025 annual earnings of $11.8 million.

That is the real debate now: whether improving consumable demand is strong enough to carry the business through softer equipment quarters.

What to watch on the August 7 call

The quarter is already posted. What matters now is whether today's August 7, 2026 conference call gives investors enough confidence in the next few quarters.

The main positive signal

Listen for whether management frames record consumables as the start of a more durable revenue stream, not just a helpful offset to weaker equipment sales. Already, the company has said consumable applicators set all time records, and Q2 reported applicator revenue increased by 13%. If that trend continues even while system sales face pressure, the bull case gets cleaner.

Three watchpoints for investors

1. Why did profitability weaken despite a revenue beat?
   The results showed $9.7 million in revenue, but also an operating loss of $(0.3) million and adjusted EBITDA of $1.2 million versus $3.2 million a year earlier.

2. Is the used-equipment issue easing or still pressuring new demand?
   Management said capital sales were hurt by stress in our customer base and by used Ultramist systems in the market. Investors should listen for signs about whether the trade-in program is stabilizing demand or simply delaying purchases.

3. Is this a one-quarter wobble or the start of a pattern?
   The market already knows the business swung from annual earnings of $11.8 million in fiscal 2025 to Q1 2026 earnings of -$1.4 million. Q2 added another mixed signal. Without a repeatable uptrend in consumable uptake and clearer system-placement stabilization, this still looks more like a volatile quarter than a fully recovered story.

My view after the call is simple: watchful, not convinced. Over the next few quarters, investors need to see whether consumable momentum holds and whether Sanuwave can convert that momentum into more dependable earnings. Until then, this looks like a business still proving recovery rather than one that deserves credit for a headline beat alone.